ALDOB and neoplasm: Again, good prognosis was observed in patients with low ALDOB expression in tumor tissue (T ≤ N) (Fig. 1B lower panel), suggesting that ALDOB expression sensitizes CRC to the anticancer agents 5-FU and oxaliplatin.